Ma et al. [46] examining cardiomyopathy in mice, found that blocking TLR2 activity blunted cardiac dysfunction and inhibited cardiac fibrosis, whereas blocking TLR4 exacerbated cardiac dysfunction and fibrosis. This evidence concerns the gene TLR2 and cardiomyopathy.